Logo

Tema Cardiovascular and Metabolic ETF

HRTS

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Prev… read more

-

ETF

Equity

- years

45 holdings

Price

per share adjusted in USD

$29.26

Price

+1.93%

$0.56

Market Cap

$48.077m

Small

$27.924k

Avg Volume
Assets Under Management

$81.704m

$33.05

NAV

0.75%

Expense Ratio

Dividends

Ex-Dividend: December 11, 24

1.61%

Yield

$0.47

Dividend

Dividends

Dividend history
No items found.
Yield
Benchmark
Sectors
Top 100 Holdings
↑ TopSummaryPriceDividendsHoldings